Matilde Otero-Losada
Overview
Explore the profile of Matilde Otero-Losada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Herrera M, Udovin L, Kobiec T, Toro-Urrego N, Kusnier C, Kolliker-Frers R, et al.
Front Behav Neurosci
. 2023 Jan;
16:1115398.
PMID: 36600990
[This corrects the article DOI: 10.3389/fnbeh.2022.953157.].
12.
Loureiro D, Bilbao R, Bordet S, Grasso L, Otero-Losada M, Capani F, et al.
Neurol Sci
. 2022 Dec;
44(4):1211-1222.
PMID: 36542202
Background: Cognitive impairment is a frequent disabling feature of Parkinson's disease (PD). Orthostatic hypotension (OH) is treatable and may be a risk factor for cognitive impairment. Objective: We conducted a...
13.
Herrera M, Udovin L, Kobiec T, Toro-Urrego N, Kusnier C, Kolliker-Frers R, et al.
Front Behav Neurosci
. 2022 Sep;
16:953157.
PMID: 36090655
Impaired gas exchange close to labor causes perinatal asphyxia (PA), a neurodevelopmental impairment factor. Palmitoylethanolamide (PEA) proved neuroprotective in experimental brain injury and neurodegeneration models. This study aimed to evaluate...
14.
Otero-Losada M, Petrovsky N, Alami A, Crispo J, Mattison D, Capani F, et al.
Expert Opin Drug Saf
. 2022 Aug;
22(4):343-349.
PMID: 36043937
Background: Information on neurological and psychiatric adverse events following immunization (AEFIs) with COVID-19 vaccines is limited. Research Design & Methods: We examined and compared neurological and psychiatric AEFIS reports related...
15.
Kolliker Frers R, Otero-Losada M, Kobiec T, Udovin L, Aon Bertolino M, Herrera M, et al.
Front Immunol
. 2022 Aug;
13:912005.
PMID: 35967312
Multiple sclerosis (MS) is an inflammatory neurodegenerative disease characterized by demyelination, progressive axonal loss, and varying clinical presentations. Axonal damage associated with the inflammatory process causes neurofilaments, the major neuron...
16.
Otero-Losada M, Gubellini P, Capani F, Perez-Lloret S
Front Pharmacol
. 2021 Dec;
12:813471.
PMID: 34955865
No abstract available.
17.
Kolliker Frers R, Otero-Losada M, Kobiec T, Herrera M, Udovin L, Kusnier C, et al.
Mediators Inflamm
. 2021 Oct;
2021:2503378.
PMID: 34697538
Autoinflammatory and autoimmune diseases are characterized by an oversensitive immune system with loss of the physiological endogenous regulation, involving multifactorial self-reactive pathological mechanisms of mono- or polygenic nature. Failure in...
18.
Otero-Losada M, Wandosell F, Capani F
Front Synaptic Neurosci
. 2021 Sep;
13:746487.
PMID: 34539374
No abstract available.
19.
Kolliker-Frers R, Udovin L, Otero-Losada M, Kobiec T, Herrera M, Palacios J, et al.
Mediators Inflamm
. 2021 Jun;
2021:9999146.
PMID: 34158806
The concept of central nervous system (CNS) inflammation has evolved over the last decades. Neuroinflammation is the response of reactive CNS components to altered homeostasis, regardless of the cause to...
20.
Kobiec T, Otero-Losada M, Chevalier G, Udovin L, Bordet S, Menendez-Maissonave C, et al.
Front Synaptic Neurosci
. 2021 May;
13:638519.
PMID: 33967734
Parkinson's disease (PD) is an extrapyramidal disorder characterized by neuronal degeneration in several regions of the peripheral and central nervous systems. It is the second most frequent neurodegenerative disease after...